Lv435
598 积分 2021-04-05 加入
Biopharmaceutical Switching in Psoriasis Treatment
1天前
已完结
Efficacy of switches within the class of IL ‐17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy ( BIOREP )
1天前
已完结
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study
1天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
4天前
已完结
Ivarmacitinib in patients with moderate to severe atopic dermatitis stratified by baseline characteristics: a post-hoc analysis of a phase 3 clinical trial
4天前
已完结
Effect of ivarmacitinib on swelling and tenderness in small and large joints and imaging changes in patients with moderate-to-severe RA: a post hoc analysis of a phase III clinical trial
4天前
已完结
Predictors of Efficacy Maintenance After Vunakizumab Discontinuation in Patients With Moderate‐to‐Severe Plaque Psoriasis: A Post Hoc Analysis of a Randomized Controlled Trial
4天前
已完结
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial
4天前
已完结
Safety and Efficacy of Recaticimab in Dyslipidemia: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
7天前
已完结
Safety, pharmacokinetics, and bioequivalence of vunakizumab injection, a specific dermatitis drug, in healthy Chinese volunteers: an open-label, randomized, two-stage, two-sequence cross-over study
11天前
已完结
皖公网安备34019202002308
